Crinetics Pharmaceuticals, Inc. (CRNX) Social Stream
CRINETICS PHARMACEUTICALS INC (CRNX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CRNX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 4 | $42 | $35 | $37.5 | $37.92 | -1.11% |
| 2021-11-23 | 5 | $68 | $35 | $43.4 | $37.92 | 14.45% |
| 2022-02-02 | 5 | $68 | $35 | $43.333 | $37.92 | 14.27% |
| 2022-05-16 | 6 | $68 | $35 | $43.833 | $37.92 | 15.59% |
| 2022-05-26 | 6 | $68 | $35 | $44.333 | $37.92 | 16.91% |
| 2022-08-15 | 6 | $68 | $35 | $44.5 | $37.92 | 17.35% |
| 2022-11-18 | 5 | $44 | $35 | $39.4 | $37.92 | 3.9% |
| 2023-01-13 | 5 | $44 | $35 | $38.5 | $37.92 | 1.53% |
| 2023-03-01 | 6 | $44 | $35 | $38.5 | $37.92 | 1.53% |
| 2023-03-10 | 6 | $44 | $35 | $38.8 | $37.92 | 2.32% |
| 2023-03-26 | 7 | $44 | $35 | $38.8 | $37.92 | 2.32% |
| 2023-03-27 | 7 | $57 | $35 | $41.833 | $37.92 | 10.32% |
| 2023-05-05 | 8 | $57 | $35 | $43.714 | $37.92 | 15.28% |
| 2023-06-08 | 8 | $57 | $35 | $46 | $37.92 | 21.31% |
| 2023-08-08 | 7 | $57 | $35 | $46 | $37.92 | 21.31% |
| 2023-08-09 | 7 | $57 | $32 | $44 | $37.92 | 16.03% |
| 2023-08-31 | 8 | $57 | $32 | $43.5 | $37.92 | 14.72% |
| 2023-09-11 | 8 | $60 | $32 | $44.625 | $37.92 | 17.68% |
| 2023-09-12 | 9 | $60 | $33 | $46.555 | $37.92 | 22.77% |
| 2023-10-23 | 8 | $60 | $33 | $45.875 | $37.92 | 20.98% |
| 2023-11-08 | 9 | $60 | $33 | $46.333 | $37.92 | 22.19% |
| 2023-11-10 | 10 | $57 | $33 | $46 | $37.92 | 21.31% |
| 2023-12-19 | 10 | $57 | $42 | $47.555 | $37.92 | 25.41% |
| 2023-12-20 | 11 | $62 | $35 | $46.8 | $37.92 | 23.42% |
The Trend in the Analyst Price Target
Over the past 20 months, CRNX's average price target has gone up $1.89.
CRNX reports an average of 100.41% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-09 | 6 | 44 | 35 | 38.800 | 18.20 | 113.19% |
| 2023-03-27 | 8 | 57 | 35 | 41.833 | 15.93 | 162.61% |
| 2023-05-05 | 9 | 57 | 35 | 43.714 | 22.35 | 95.59% |
| 2023-08-08 | 7 | 57 | 35 | 46.000 | 17.30 | 165.9% |
| 2023-08-31 | 8 | 57 | 32 | 43.500 | 17.32 | 151.15% |
CRNX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.18 | 10 | 0 | 1 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
Over the past 26 weeks, CRNX's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how CRINETICS PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 3292.88% of that group.
- CRINETICS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 2944.25% of stocks in the small market cap category.
- In the context of Pharmaceutical Products stocks, CRINETICS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 818.87% of them.
- In terms of how CRINETICS PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -1174.15% of that group.
In the Pharmaceutical Products industry, KZR, VRCA, and ITRM are the three stocks most similar to CRINETICS PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding CRNX using the data that counts. Try POWR Ratings for free.